Authors
David D Bowtell, Steffen Böhm, Ahmed A Ahmed, Paul-Joseph Aspuria, Robert C Bast Jr, Valerie Beral, Jonathan S Berek, Michael J Birrer, Sarah Blagden, Michael A Bookman, James D Brenton, Katherine B Chiappinelli, Filipe Correia Martins, George Coukos, Ronny Drapkin, Richard Edmondson, Christina Fotopoulou, Hani Gabra, Jérôme Galon, Charlie Gourley, Valerie Heong, David G Huntsman, Marcin Iwanicki, Beth Y Karlan, Allyson Kaye, Ernst Lengyel, Douglas A Levine, Karen H Lu, Iain A McNeish, Usha Menon, Steven A Narod, Brad H Nelson, Kenneth P Nephew, Paul Pharoah, Daniel J Powell Jr, Pilar Ramos, Iris L Romero, Clare L Scott, Anil K Sood, Euan A Stronach, Frances R Balkwill
Publication date
2015/11
Source
Nature reviews Cancer
Volume
15
Issue
11
Pages
668-679
Publisher
Nature Publishing Group UK
Description
High-grade serous ovarian cancer (HGSOC) accounts for 70–80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015.
Scholar articles
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria… - Nature reviews Cancer, 2015